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Abstract 
Before ultrasound-imaging systems became widely available, ultrasound therapy devices showed great promise for general use in 
medicine. However, it is only in the last decade that ultrasound therapy has begun to obtain clinical acceptance.  Recently, a 
variety of novel applications of therapeutic ultrasound have been developed that include sonothrombolysis, site-specific and 
ultrasound-mediated drug delivery, shock wave therapy, lithotripsy, tumor ablation, acoustic hemostasis and several others. This
paper reviews a few selected applications of therapeutic ultrasound.  It will address some of the basic scientific questions and
future challenges in developing these methods and technologies for general use in our society. As a plenary presentation, its 
audience is intended for the ultrasound scientist or engineer, and thus is not presented at the level of the experienced medical
ultrasound professional.  
PACS: 43.25.Yw; 43.25.Nm; 43.25.Qp 
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Introduction 
Ultrasound is one of the most commonly used imaging modalities in all of medicine and is particularly well 
known for its ability to image the developing foetus; however, ultrasound offers an enormous, and so far mostly 
unrealized, potential for image-guided therapy.  
This potential was anticipated more than 50 years ago, before diagnostic ultrasound had achieved even an early 
stage of development, when the Fry brothers were able to use High Intensity Focused Ultrasound (HIFU) to perform 
“surgery” on patients with Parkinson’s disease. Recently, therapeutic ultrasound is being investigated in a number of 
modalities for the treatment of a variety of medical conditions; for example, see the excellent review by Mitragotri 
[1]. For reference, Fig. 1 shows a sketch of the acoustic parameters associated with therapeutic ultrasound and their 
approximate value for a few specific applications. This paper addresses a few of the topics presented in a general 
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plenary lecture given at the 2nd ICU in Santiago, Chile, and is intended as a brief review of some selected topics in
therapeutic ultrasound for the ultrasound scientist or engineer, and not for the specialist in medical ultrasound.
Fig.1  Some representative acoustic parameters.
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Sonothrombolysis
Although we can not survive without blood flowing though our vascular system, blood clots are a major nemesis, 
causing infarctions in the heart and blockages in the brain; indeed, strokes are the leading cause of disability in the 
United States. Doppler ultrasound is well known for its ability to image the entire vascular tree, and major progress 
is being made in the use of ultrasound for both imaging of the clot, as well as inducing or accelerating clot lysis. A 
now famous study was conducted by Alexandrov, et al. [2] which demonstrated that the use of transcranial Doppler 
ultrasonography combined with a thrombolytic drug (t-PA) could significantly improve the recanalization rate of the 
blocked artery or result in a dramatic clinical recovery of the patient. This important discovery has accelerated a 
number of investigations into the use of ultrasound for clot dissipation, an area of research called 
“sonothrombolysis”, see for example [3].  In particular, considerable efforts are focused on this non-invasive 
approach to clot dissolution. 
Although there is great interest in the clinical application of sonothrombolysis, there are still unanswered 
questions concerning the physical mechanisms that give rise to this effect.  Ultrasound, by itself, should not exhibit 
significant forces on a clot, at least to first order; it is the difference in acoustic impedance that results in radiation 
force, and a clot’s acoustic impedance would differ only slightly from that of the surrounding blood.  Of course, 
acoustic streaming can occur in blood due to the absorption of sound [4], but it is difficult to obtain significant 
streaming with a Doppler waveform alone.  On the other hand, if microbubbles are present, then streaming can be 
greatly enhanced [5] due to the strong radiation forces exerted by ultrasound on bubbles, as well as microstreaming 
induced by the pulsations of the bubbles themselves; thus, there is significant research activity in the combined use 
of ultrasound contrast agents (stabilized microbubbles) together with pulsed ultrasound, with and without a 
thrombolytic drug. It is likely that when ultrasound is combined with t-PA alone (no ultrasound contrast agents), 
there are sufficient cavitation nuclei in the host fluid itself to induce some level of radiation-force type streaming. A 
second concept that may be important is one generally termed “pulsatility” [6], in which the PRF of the Doppler 
signal could induce a pulsation of the clot.  Under this scenario, the clot could be distorted under the action of 
radiation force and pump the drug in and out of the clot—which should result in increased lysis.  If such a scenario 
exists, then modifying the PRF until maximum pulsatility is achieved (which can be measured with ultrasound) 
should result in increased clot lysis. 
Finally, although non-invasive approaches are particularly attractive, there are FDA-approved minimally-
invasive devices, such as the EKOS series of transducer-tipped catheters, that have been proven effective for 
sonothrombolysis [7]. 
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Ultrasound-enhanced drug delivery
Genetic engineering offers great promise for significant advances in health care and the treatment of a number of
diseases.  In order to treat hereditary genetic disorders, such as haemophilia, the defective gene must be replaced
within the DNA of the defective cell nucleus. If the cell can then express this repaired DNA, by transfection of the
missing protein, such as Clotting Factor VIII for haemophilia, then the disease can theoretically be cured [8].  The
most common approach for this gene insertion is to modify a virus, which has evolved to reproduce only by
managing to insert itself and its genetic material into the nucleus.  However, viral-based gene therapy has had its
setbacks and alternative approaches are being sought. One approach is to use ultrasound to transiently open the cell 
membrane, thus permitting the genetic material to be taken up by the cell.  This temporary, ultrasound-induced, cell 
permeability is typically called sonoporation, and this general approach ultrasound-enhanced drug delivery.  Of 
course, one can also envision using this uptake of drugs to kill the cell, as in the treatment of benign and malignant
tumors.
There has been considerable research activity directed toward the understanding of the basic physical
mechanisms that gives rise to transient cell permeability. It is believed that the principal mechanism is cavitation,
although there is some disagreement as to the specific type of cavitation that results in sonoporation.  For example,
if the acoustic driving pressure is sufficiently high, a gas-filled nucleation site will grow to several times its initial
radius and collapse with considerable violence.  If the collapse depends more on the mass of liquid surrounding the
bubble than on the stiffness of the gas contained within the bubble, this type of cavitation is termed “inertial
cavitation” and the event typically lasts for only a few cycles. When the source pressure is low, and the bubble’s
collapse is controlled by the stiffness of the gas, this type of cavitation is called “stable cavitation” and the bubble
typically survives for thousands of cycles. These two different types of cavitation would induce sonoporation in 
different ways.
Shown in Fig. 2 is an example of inertial cavitation and it potential for affecting cells. 
Fig.2  Examples of potential cell-damage mechanisms arising from inertial cavitation:
(left) An example of a collapsing bubble that has entrained a liquid jet; (middle)
example of a shock wave emitted from a collapsed cavitation bubble; (right) image of
a cell that has been exposed to inertial cavitation showing damage sites [9].
If the bubble collapse is violent, and near a boundary, high-speed liquid jets can develop at the final stages of
collapse which can penetrate several jet diameters into solid metal. If the collapse is spherical, strong shock waves
can develop which also have the capability of damaging nearby interfaces. Thus, inertial cavitation most certainly
has the capability to induce membrane permeability in cells in the vicinity of cavitation.
If one is interested in destroying cells, then cavitation can be very effective, at least in an in vitro suspension.
However, if one wishes to use ultrasound for gene therapy, then it is important not to kill the cell, but to induce it to 
take up genetic material, survive, undergo transfection and express (produce) the desired protein. In this case, one
wants only to slightly injure the cell and induce cell permeability.  Probably the best way to do this is to use stable
cavitation, wherein the shear forces induced by acoustic streaming in the vicinity of the oscillating bubble can 
permeabilize the cell membrane.  Some recent results by Forbes, et al., [10] suggest that the threshold for
sonoporation is lower than that for inertial cavitation, and the yield is higher when only stable cavitation is 
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produced. On the other hand, Miao, et al., [8] have demonstrated that intensities much higher than the inertial
cavitation threshold are necessary when gene transfection is to be produced in vivo.  Suffice it to say that this is an
active area of research with considerable promise for clinical applications.
Shock Wave Therapy; Lithotripsy
Kidney stones afflict 13% of men and 7% of women in the U.S., and comparable statistics apply worldwide. The
prevalence of kidney stones varies dependent on race, sex, age, and geographic location; however, stone formers can
be any age, and many develop multiple stones at a time. Some stones pass spontaneously; however, those that don’t
account for 1% of all hospitalizations annually in the U.S.
Shock Wave Lithotripsy is the most common treatment used for stone disease today. Shock waves generated
outside the body are focused to a fixed location. The patient, usually under anaesthesia or conscious sedation, is
positioned with the stone within this focal zone. Between 1500 and 4000 shock waves are applied at about 2 Hz
(range 1-4 Hz).
Fig.3  Illustration of shock wave lithotripsy. (left) Kidney stones removed from a patient (bar = 1 cm);
(middle) shock waveform generated by typical lithotripter; (right) application of only 75 shock waves 
induces stone comminution.
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The shock waves travel through water into the body. In the original lithotripter, the Dornier HM-3, the patient
rested in a water bath. All current lithotripters have the SW source enclosed in a water-filled pillow that is coupled
to the patient’s skin. Treatment outcome is measured by stone-free rates after 1 to 3 months, and by re-treatment
rates. Stone-free rates range from 40-90% with different machines; newer machines have lower stone-free rates and 
higher re-treatment rates. Fig. 3 shows some results of a typical lithotripter application.
When a shock wave with a very rapid rise time (< 50 ns), a positive pressure amplitude of 35 MPa, and a
negative pressure amplitude of about 10 MPa is delivered to a stone, it breaks into many small pieces, typically in
less than 100 shock waves. However, a typical clinical treatment usually results in over 1000 shock waves delivered.
Of course, if the stones are not broken until each fragment is less than about 2 mm, natural stone passage can be
complicated.
There is a continuing disagreement on the actual mechanism that results in stone comminution.  Since the typical 
shock wave used in lithotripsy has a negative pressure in excess of 10 MPa, cavitation is not only likely to be 
present, but also to be quite violent. It is thus not unreasonable to expect that cavitation plays a significant role in 
stone comminution [11]. When a shock wave reflects from an interface, negative pressures can be doubled, and
spallation is a well-known mechanism for material fracture. However, Sapozhnikov et al., [12] have developed a 
numerical model for shock wave propagation in synthetic stones and determined that the highest tensile stress
developed within the stone results from shear waves initiated at the proximal corners of the stone, and that spallation
results in considerably lower tensile stresses.  Novel experiments that isolated the various stress contributions were
performed that supported the modelling results. These various experimental and numerical studies suggest that shear 
waves result in the initial fragmentation of the stone into smaller pieces, but cavitation plays a much larger role in 
further reducing the sizes of the fragments into those that would naturally pass through the urinary tract. 
An important discovery in lithotripsy research is that reducing the shock wave repetition rate from 2 Hz (a 
commonly used rate) to 0.5 Hz significantly improves stone comminution, and interestingly, also reduces tissue
damage [13].
Fig.4  Effect of shock wave repetition rate on stone comminution. (left-top) Stone
fragmentation when shock waves are delivered at 2 Hz, (left-bottom) fragmentation at 
0.5 Hz; (middle) bubble population near focus with 0.5 Hz rate; (right) bubble population
with 2.0 Hz rate.
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Shown in Fig. 4 is an illustration of this effect and some evidence that it is due to screening of the stone by
cavitation bubbles produced by the shock waves.  Once a shock wave propagates through a liquid, the cavitation
produced can transfer dissolved gas from the liquid into free gas in the bubble, through a process generally termed
rectified diffusion. Once these bubbles are formed, they slowly dissolve, but if a second pulse arrives before the
bubbles from the previous cavitation event have not yet dissolved, then these daughter bubbles act as cavitation
nuclei and more bubbles are produced.  Once a large number of bubbles are present in the shock wave path,
screening of the stone from the shock wave can occur.
High Intensity Focused Ultrasound
One of the most promising applications of therapeutic ultrasound is that of image-guided therapy in which High
Intensity Focused Ultrasound (HIFU) is used to ablate benign and malignant tumors through a completely non-
invasive procedure. Although neither magnetic resonance nor ultrasound imaging was available at the time, non-
invasive HIFU was used to treat patients with Parkinson’s and other neurological diseases by the Fry brothers over
50 years ago [14]. With the advent of the increased capabilities of diagnostic ultrasound, Chinese investigators
developed ultrasound-guided HIFU in the late 1990s and tens of thousands of patients have been treated to date [15].
Because it is possible to perform thermometry with MR imaging, the first device approved in the United States uses
MR-guidance [16], and patients are routinely being treated for uterine fibroids [17].
An illustration of one particular ultrasound-guided system in current use in China, and in our laboratory, is given
in Fig. 5. Using ultrasound imaging, one can clearly distinguish targets of interest, such as a uterine fibroid,
provided there is a readily-available acoustic window. This clinical system uses a high-end diagnostic ultrasound
system to locate the tumor, and then a focused ultrasound transducer to target the tumor and supply the HIFU
necessary for  thermal ablation. Although the intensities used in these systems are high enough to produce
cavitation, this phenomenon probably doesn’t play a major role in ablation.  Indeed, when HIFU is applied to tissue,
it is not uncommon to see hyperechoic regions in the image that might be interpreted as cavitation [18], although
recent studies suggest that these hyperechoes are most probably gas and vapor produced by boiling [19]. 
One of the challenges of using a completely non-invasive ablation approach is that it is difficult to determine the
end result of a HIFU treatment. Various approaches are used but most of them involved pre-and post contrast
imaging.
Fig.5  Illustration of ultrasound-image-guided HIFU. (left) A clinical HIFU machine used by the
Yuande Corporation in China; (right) Images pre- and post-treatment of a double uterine fibroid
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showing that HIFU-induced ablation essentially stops vascular perfusion.
It is presumed that in a successful treatment, the tumor and a surrounding margin is completely ablated by the
HIFU, through a process called coagulative necrosis.  In this scenario, the tissue is heated to the point for which
protein denaturation occurs, and thus the tissue and blood is irreversibly damaged (like cooking an egg). One can
thus determine, to some extent, the region of complete ablation by imaging the region of interest with a contrast
agent that is carried by the blood. Presumably, if the blood supply to a tumor is terminated, then the tissue must
either be dead, or will soon die.  An illustration of this effect is shown in Fig. 5 in which two uterine fibroids were
treated with an ultrasound-image-guided HIFU system.  Before the treatment, the fibroids were imaged with
ultrasound, using an ultrasound contrast agent (stabilized microbubbles); after treatment, the treated region shows no 
contrast agent uptake, thus indicating that the tumor’s blood supply has been stopped.
It is possible to imagine a large number of applications of image-guided therapy and research in this area is 
rapidly expanding.  One application that has captured our own interest is the use of HIFU to terminate bleeding, an
application that we call “acoustic hemostasis”. Our research has demonstrated the successful use of HIFU to induce 
hemostasis in a number of cases [20, 21]. In this last example of therapeutic ultrasound, we show an example of its
use in trauma. When individuals are involved in automobile accidents, high decelerations often occur (one collides
with another vehicle).  Since the liver is a large organ, is highly perfused with blood, and can not sustain high shear
loads (it tears easily), it is not uncommon for uncontrolled bleeding of the liver (and spleen) to occur in patients who
have been involved in an automobile accident.  Unless this bleeding can be stopped, exsanguination (bleeding to 
death) can result.  Indeed, exsanguination is the principal cause of death in combat [22] and is a large fraction of
those dying from blunt trauma [23]. Shown in Fig. 6 is an illustration of how image-guided HIFU can be used to
treat bleeding in a porcine animal model.
Fig.6  Illustration of the use of Image-guided HIFU to induce vascular occlusion in an animal model.  Here a blood vessel that is 
causing the bleeding is targeted and then treated with HIFU until spectral Doppler indicates that the blood flow in the damaged
vessel has been terminated.
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In this example of image-guided acoustic hemostasis, an ultrasound scan is made of the liver, the (bleeding) 
vessel of interest targeted, and HIFU applied, in an effort to reduce the bleeding.  Spectral Doppler, which can 
measure flow rate, is used to monitor the progress of the therapy.  In a real case of trauma, a first responder would 
first try to find the major “bleeder” and apply pressure so as to reduce the blood flow. If “haemorrhage control” can 
be achieved, providing sufficient time to transport the injured patient to the operating room, then patient survival 
rates could be significantly improved.  With ultrasound, one can use Doppler imaging to detect bleeding because the 
entire vascular tree can be imaged. It is also possible to apply certain imaging algorithms to determine if a particular 
branch point in the vascular tree is a normal connected one or one that is open and bleeding. 
Summary 
In this paper, we have provided a few examples of the current trends in the use of therapeutic ultrasound in 
medicine, and some discussion of its potential for widespread use.  The major promise of this new non-invasive 
technology is to introduce methods and approaches that now do not exist, and/or to reduce the morbidity associated 
with conventional therapy.  A large percentage of operations are now being performed using laparoscopic 
procedures that significantly reduce morbidity, and hospital stays associated with invasive surgery.  It is only 
reasonable that completely non-invasive procedures are the natural progression of these new and emerging 
technologies, and the operating room of the future may well be a hand-held image-guided therapy system not unlike 
the “tricorder” of Star Trek fame. 
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